Deckers Outdoor Corp (DECK) Stock Price Today
Aura AI Summary
Key Stats
- $13.19BMarket Cap
- -Volume
- Consumer CyclicalSector
- $123.9152W High
- $79.5452W Low
- -Typical Hold Time
- $12.06BEnterprise Value
- -Div Yield
- -Trading Activity
Track Deckers Outdoor Corp (DECK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Deckers Outdoor Corp has traded between a low of $79.54 and a high of $123.91, highlighting its annual price range. Buy and sell Deckers Outdoor Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Deckers Outdoor Corp
Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Most Recent News
Jyske Realkredit releases preliminary data on early bond redemptions as of July 31, 2026
Jyske Realkredit A/S has published preliminary data on early redemptions (prepayments) of its bonds up to July 31, 2026. This information is part of regulatory disclosure under the Capital Markets Act and is available on their website and Nasdaq Nord...

Investec Bank discloses share dealings in Advanced Medical Solutions on July 31, 2026.
Investec Bank plc, acting as advisor and joint broker to Advanced Medical Solutions Group Plc, disclosed its share transactions on July 31, 2026. The bank purchased 358,730 ordinary shares at prices between 280 and 280.25, and sold 431,803 shares wit...

AstraZeneca shares drop 6% amid confusion over potential Bristol Myers Squibb buyout talks
AstraZeneca's shares fell 6% following reports of talks to acquire Bristol Myers Squibb, leaving analysts puzzled. Despite AstraZeneca's strong growth and innovation, brokers like Jefferies and UBS question the strategic timing and benefits of the de...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.